CCR6 and neoplasm: Flow cytometry analysis of 344SQ and 393P tumor tissues showed an increase in CCR5+, CCR6+, and IL-17+RORγt+ CD4+ T cells in tumors that developed resistance to therapy (Fig. 3c, d; Supplementary Fig. 4d).